ACOG

Alpha Cognition Inc. Common Stock NASDAQ Listed Nov 12, 2024

Financial Services ·Financial - Conglomerates ·CA · alphacognition.com

$6.09

Mkt Cap $94.6M

52w Low $4.50 22.6% of range 52w High $11.54

50d MA $6.08 200d MA $6.74

P/E (TTM) -5.1x

EV/EBITDA -2.2x

P/B 1.7x

Debt/Equity 0.0x

ROE -33.1%

P/FCF -5.6x

RSI (14) —

ATR (14) —

Beta 2.52

50d MA $6.08

200d MA $6.74

Avg Volume 69.3K

Alpha Cognition Inc., a clinical stage biopharmaceutical company, engages in the development of treatments for Alzheimer's disease and amyotrophic lateral sclerosis (ALS). The company offers ZUNVEYL (benzgalantamine) for the treatment of mild-to-moderate Alzheimer's disease and mild traumatic brain injury. It also develops ALPHA-0602, a gene therapy for the treatment of ALS; and ALPHA-0702 and ALPHA-0802, a granulin epithelin motifs for the treatment of neurodegenerative diseases. The company was formerly known as Crystal Bridge Enterprises Inc. and changed its name to Alpha Cognition Inc. in March 2021. Alpha Cognition Inc. was founded in 2000 and is headquartered in Vancouver, Canada.

SIC Code

2836

CIK (SEC)

1655923

Phone

858 344 4375

750 West Pender Street · Vancouver, BC V6C 2T8 · CA

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Mar 26, 2026	AMC	-0.27	-0.30	-11.1%	5.34	-6.2%	-4.9%	+4.7%	+3.2%	+8.6%	+0.3%	—
Nov 13, 2025	AMC	-0.43	-0.30	+30.2%	6.13	-2.1%	-3.1%	-0.7%	+5.6%	-5.0%	-1.5%	—
Aug 14, 2025	AMC	-0.46	-0.65	-41.3%	8.00	+6.5%	+0.0%	+5.6%	-4.3%	-1.1%	+3.2%	—
May 15, 2025	AMC	-0.58	-0.20	+65.5%	6.81	+5.0%	+27.0%	+15.6%	+5.8%	-6.9%	-11.8%	—
Mar 31, 2025	AMC	-0.48	-0.51	-6.2%	5.06	+3.8%	-4.2%	+4.7%	-1.8%	-3.2%	-8.3%	—
Nov 14, 2024	AMC	-1.00	-0.31	+69.0%	5.68	-1.4%	-5.5%	+6.1%	-0.7%	+2.1%	-0.5%	—
Aug 12, 2024	AMC	-1.00	-0.35	+64.8%	—	—	—	—	—	—	—	—
Mar 31, 2024	AMC	—	-0.87	—	—	—	—	—	—	—	—	—
Dec 31, 2023	AMC	—	-1.55	—	—	—	—	—	—	—	—	—
Sep 30, 2023	AMC	—	-0.84	—	—	—	—	—	—	—	—	—
Jun 30, 2023	AMC	—	-0.74	—	—	—	—	—	—	—	—	—
Mar 31, 2023	AMC	—	-0.60	—	—	—	—	—	—	—	—	—

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Apr 27	HC Wainwright & Co.	Maintains	Buy → Buy	—	$6.86	$6.75	-1.6%	-6.3%	-3.6%	-5.3%	+1.7%	-0.3%
Dec 19	HC Wainwright & Co.	Maintains	Buy → Buy	—	$5.05	$5.05	+0.0%	+10.1%	+8.6%	-1.2%	+4.7%	+0.3%
Oct 20	HC Wainwright & Co.	Maintains	Buy → Buy	—	$6.80	$6.82	+0.3%	+4.9%	-3.9%	+0.7%	+1.3%	-1.7%
May 16	HC Wainwright & Co.	Maintains	Buy → Buy	—	$6.81	$7.15	+5.0%	+27.0%	+15.6%	+5.8%	-6.9%	-11.8%
Apr 1	HC Wainwright & Co.	Maintains	Buy → Buy	—	$5.06	$5.25	+3.8%	-4.2%	+4.7%	-1.8%	-3.2%	-8.3%
Mar 31	HC Wainwright & Co.	Maintains	Buy → Buy	—	$5.53	$5.41	-2.2%	-8.5%	-4.2%	+4.7%	-1.8%	-3.2%

Data updated apr 24, 2026 10:39am · Source: massive.com